Title: Josef Haala - Innovator in Pharmaceutical Composition
Introduction
Josef Haala is an inventor based in Pullach, Germany. He has made significant contributions to the field of pharmaceutical compositions, focusing on innovative methods for drug delivery. Although he currently holds no granted patents, his work in the industry is noteworthy.
Latest Patent Applications
Josef Haala's latest patent applications include:
1. **Oral Granules with Combination of Extended-Release and Quick-Release Magnesium, and Production Methods** - This invention enables direct oral granules that allow for controlled release of magnesium, featuring both extended-release and non-extended-release fractions. The granules consist of extended-release particles with a magnesium-containing core and a lipophilic coating. The cores of these particles are designed to have mandated abrasion resistance, allowing them to be melt-coated with lipids in a fluidized bed.
2. **Oral Pharmaceutical Composition Comprising a Melt-Agglomerated Active Ingredient Core** - This invention relates to coated particles that contain a taste-masked drug substance. The particles include a core with a melt-agglomerated active pharmaceutical ingredient (API) and a coating made of a triglyceride and a surfactant. These particles are designed to exhibit immediate drug release and a stable release profile, with a method for manufacturing them that prevents the degradation of thermolabile active pharmaceutical ingredients.
Conclusion
Josef Haala's innovative approaches to pharmaceutical compositions highlight his commitment to advancing drug delivery methods. His latest patent applications reflect his expertise and potential impact in the field.